Offer - Urjas Oil for just ₹ 1 X
Acrotac 25 Capsule is a prescription medicine that is available as a Capsule. It is typically used for the treatment of Psoriasis. Acrotac 25 Capsule also has some secondary and off-label uses. These are listed below.
The optimal dosage of Acrotac 25 Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Acrotac 25 Capsule have been listed ahead. Normally, these side effects of Acrotac 25 Capsule are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Acrotac 25 Capsule's effect during pregnancy is Severe and Severe while nursing. Further, the section on Acrotac 25 Capsule related warnings talks about Acrotac 25 Capsule's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Liver Disease must refrain from the use of Acrotac 25 Capsule since this can cause severe adverse effects. The section on Acrotac 25 Capsule contraindications lists all such conditions.
Drug interactions for Acrotac 25 Capsule have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Acrotac 25 Capsule is safe while driving, and is is addictive in nature.
Acrotac 25 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Acrotac 25 Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Acrotac. If you are pregnant, do not take Acrotac without a doctor's advice.
Is the use of Acrotac 25 Capsule safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Acrotac. So it is adviced to consult the doctor before using it.
What is the effect of Acrotac 25 Capsule on the Kidneys?
Acrotac rarely harms the kidneys.
What is the effect of Acrotac 25 Capsule on the Liver?
Very few cases of side effects of Acrotac on the liver have been reported.
What is the effect of Acrotac 25 Capsule on the Heart?
Acrotac can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Acrotac 25 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Acrotac 25 Capsule unless your doctor advises you to do so -
Is this Acrotac 25 Capsule habit forming or addictive?
Acrotac 25 Capsule does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Acrotac 25 Capsule will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, the use of Acrotac 25 Capsule is considered safe.
Is it able to treat mental disorders?
Acrotac 25 Capsule is unable to treat or cure mental disorders.
Interaction between Food and Acrotac 25 Capsule
Information is not available on the interaction of any foods with Acrotac 25 Capsule, due to a lack of research on this.
Interaction between Alcohol and Acrotac 25 Capsule
Consumption of alcohol and Acrotac 25 Capsule together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soriatane (acitretin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 892